# Bank7 Corp.: financial statements, quarterly

BSVN · Nasdaq · CIK 1746129 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsvn.md) · [Financials](/companies/bsvn/financials.md) · [Filings](/companies/bsvn/filings.md) · [Insiders](/companies/bsvn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bsvn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [11.0](/filings/0001140361-23-052295.md) | [11.1 d](/filings/0001140361-24-014984.md) | [11.3](/filings/0001140361-24-026111.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.4](/filings/0001140361-24-045199.md) | [0.5 d](/filings/0001140361-26-009657.md) | [3.6](/filings/0001140361-25-018373.md) | [3.7](/filings/0001140361-25-029593.md) | [3.7](/filings/0001140361-25-041162.md) | [3.6 d](/filings/0001140361-26-009657.md) | [3.4](/filings/0001140361-26-020594.md) | [3.6](/filings/0001140361-26-032024.md) | [3.3](/filings/0001140361-25-041162.md) | [3.4 d](/filings/0001140361-26-009657.md) | [3.8](/filings/0001140361-26-020594.md) | [2.7](/filings/0001140361-26-032024.md) |
| Net income | $m | [7.9](/filings/0001140361-24-045199.md) | [1.1 d](/filings/0001140361-26-009657.md) | [11.3](/filings/0001140361-25-018373.md) | [11.5](/filings/0001140361-25-029593.md) | [11.8](/filings/0001140361-25-041162.md) | [11.1 d](/filings/0001140361-26-009657.md) | [10.3](/filings/0001140361-26-020594.md) | [11.1](/filings/0001140361-26-032024.md) | [10.8](/filings/0001140361-25-041162.md) | [10.8 d](/filings/0001140361-26-009657.md) | [12.0](/filings/0001140361-26-020594.md) | [8.3](/filings/0001140361-26-032024.md) |
| Diluted EPS | $ per share | [0.85](/filings/0001140361-24-045199.md) | not reported | [1.21](/filings/0001140361-25-018373.md) | [1.23](/filings/0001140361-25-029593.md) | [1.24](/filings/0001140361-25-041162.md) | not reported | [1.08](/filings/0001140361-26-020594.md) | [1.16](/filings/0001140361-26-032024.md) | [1.13](/filings/0001140361-25-041162.md) | not reported | [1.25](/filings/0001140361-26-020594.md) | [0.87](/filings/0001140361-26-032024.md) |
| Basic EPS | $ per share | [0.86](/filings/0001140361-24-045199.md) | not reported | [1.22](/filings/0001140361-25-018373.md) | [1.25](/filings/0001140361-25-029593.md) | [1.26](/filings/0001140361-25-041162.md) | not reported | [1.10](/filings/0001140361-26-020594.md) | [1.18](/filings/0001140361-26-032024.md) | [1.15](/filings/0001140361-25-041162.md) | not reported | [1.26](/filings/0001140361-26-020594.md) | [0.88](/filings/0001140361-26-032024.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,772](/filings/0001140361-23-052295.md) | [1,772](/filings/0001140361-25-008438.md) | [1,775](/filings/0001140361-24-026111.md) | [1,683](/filings/0001140361-24-036309.md) | [1,740](/filings/0001140361-24-045199.md) | [1,740](/filings/0001140361-26-009657.md) | [1,785](/filings/0001140361-25-018373.md) | [1,836](/filings/0001140361-25-029593.md) | [1,891](/filings/0001140361-25-041162.md) | [1,964](/filings/0001140361-26-032024.md) | [1,945](/filings/0001140361-26-020594.md) | [1,914](/filings/0001140361-26-032024.md) |
| Total liabilities | $m | [1,604](/filings/0001140361-23-052295.md) | [1,601](/filings/0001140361-25-008438.md) | [1,595](/filings/0001140361-24-026111.md) | [1,492](/filings/0001140361-24-036309.md) | [1,536](/filings/0001140361-24-045199.md) | [1,527](/filings/0001140361-26-009657.md) | [1,564](/filings/0001140361-25-018373.md) | [1,604](/filings/0001140361-25-029593.md) | [1,650](/filings/0001140361-25-041162.md) | [1,713](/filings/0001140361-26-032024.md) | [1,685](/filings/0001140361-26-020594.md) | [1,648](/filings/0001140361-26-032024.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [168](/filings/0001140361-24-045199.md) | [170](/filings/0001140361-26-009657.md) | [180](/filings/0001140361-25-018373.md) | [191](/filings/0001140361-25-029593.md) | [204](/filings/0001140361-25-041162.md) | [213](/filings/0001140361-26-009657.md) | [222](/filings/0001140361-26-020594.md) | [232](/filings/0001140361-26-032024.md) | [242](/filings/0001140361-25-041162.md) | [251](/filings/0001140361-26-032024.md) | [260](/filings/0001140361-26-020594.md) | [266](/filings/0001140361-26-032024.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.8 d](/filings/0001140361-24-045199.md) | [16.2 d](/filings/0001140361-26-009657.md) | [20.4](/filings/0001140361-25-018373.md) | [8.1 d](/filings/0001140361-25-029593.md) | [13.4 d](/filings/0001140361-25-041162.md) | [13.1 d](/filings/0001140361-26-009657.md) | [11.0](/filings/0001140361-26-020594.md) | [9.5 d](/filings/0001140361-26-032024.md) | [16.6 d](/filings/0001140361-25-041162.md) | [9.1 d](/filings/0001140361-26-009657.md) | [16.6](/filings/0001140361-26-020594.md) | [7.5 d](/filings/0001140361-26-032024.md) |
| Capital expenditure | $m | [0.4 d](/filings/0001140361-24-045199.md) | [0.2 d](/filings/0001140361-26-009657.md) | [0.7](/filings/0001140361-25-018373.md) | [1.6 d](/filings/0001140361-25-029593.md) | [0.6 d](/filings/0001140361-25-041162.md) | [1.3 d](/filings/0001140361-26-009657.md) | [2.8](/filings/0001140361-26-020594.md) | [0.6 d](/filings/0001140361-26-032024.md) | [0.2 d](/filings/0001140361-25-041162.md) | [1.1 d](/filings/0001140361-26-009657.md) | [2.5](/filings/0001140361-26-020594.md) | [2.0 d](/filings/0001140361-26-032024.md) |
| Dividends paid | $m | [1.5 d](/filings/0001140361-24-045199.md) | [1.9 d](/filings/0001140361-26-009657.md) | [1.9](/filings/0001140361-25-018373.md) | [1.9 d](/filings/0001140361-25-029593.md) | [1.9 d](/filings/0001140361-25-041162.md) | [2.2 d](/filings/0001140361-26-009657.md) | [2.3](/filings/0001140361-26-020594.md) | [2.3 d](/filings/0001140361-26-032024.md) | [2.3 d](/filings/0001140361-25-041162.md) | [2.6 d](/filings/0001140361-26-009657.md) | [2.6](/filings/0001140361-26-020594.md) | [2.6 d](/filings/0001140361-26-032024.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [9,210](/filings/0001140361-23-052295.md) | [9,264](/filings/0001140361-24-026111.md) | [9,247](/filings/0001140361-24-036309.md) | [9,274](/filings/0001140361-24-045199.md) | [9,318](/filings/0001140361-25-018373.md) | [9,367](/filings/0001140361-25-029593.md) | [9,498](/filings/0001140361-25-041162.md) | [9,552](/filings/0001140361-26-020594.md) | [9,545](/filings/0001140361-26-032024.md) | [9,598](/filings/0001140361-25-041162.md) | [9,597](/filings/0001140361-26-020594.md) | [9,604](/filings/0001140361-26-032024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,525,856 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001140361-26-032024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.